Download Full Text (15.8 MB)
Antiangiogenic Agents: Changing the Nature of Cancer Treatment
DiaLog: Angiogenesis Research: Looking for New Ways to Measure Success, by Roy S. Herbst, MD, PhD, Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology
House Call: Overcome Fears of Cancer Recurrence by Taking Action
Recognition Spurs Prevention of Osteoporosis in Patients with Cancer
Protocols: Clinical Trials of Antiangiogenic Agents
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
The University of Texas MD Anderson Cancer Center
History of Science, Technology, and Medicine | Oncology
O'Suilleabhain, Kate; Herbst, Roy S. MD, PhD; and Wright, Kerry L., "OncoLog Volume 46, Number 05, May 2001" (2001). OncoLog MD Anderson's Report to Physicians (All issues). 95.
Conditions Governing Access